Hematopoietic stem progenitor cells with malignancy‐related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4

The phenotypic changes in hematopoietic stem progenitor cells (HSPCs) with somatic mutations of malignancy‐related genes in patients with acquired aplastic anemia (AA) are poorly understood. As our initial study showed increased CXCR4 expression on HLA allele‐lacking (HLA[−]) HSPCs that solely support hematopoiesis in comparison to redundant HLA(+) HSPCs in AA patients, we screened the HSPCs of patients with various types of bone marrow (BM) failure to investigate their CXCR4 expression. In comparison to healthy individuals (n = 15, 12.3%–49.9%, median 43.2%), the median CXCR4+ cell percentages in the HSPCs of patients without somatic mutations were low: 29.3% (14.3%–37.3%) in the eight patients without HLA(−) granulocytes, 8.8% (4.1%–9.8%) in the five patients with HLA(−) cells accounting for >90% of granulocytes, and 7.8 (2.1%–8.7%) in the six patients with paroxysmal nocturnal hemoglobinuria. In contrast, the median percentage was much higher (78% [61.4%–88.7%]) in the five AA patients without HLA(−) granulocytes possessing somatic mutations (c‐kit, t[8;21], monosomy 7 [one for each], ASXL1 [n = 2]), findings that were comparable to those (66.5%, 63.1%–88.9%) in the four patients with advanced myelodysplastic syndromes. The increased expression of CXCR4 may therefore reflect intrinsic abnormalities of HSPCs caused by somatic mutations that allow them to evade restriction by BM stromal cells.

[1]  G. Mufti,et al.  Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. , 2022, The New England journal of medicine.

[2]  S. Ogawa,et al.  Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia , 2021, Leukemia.

[3]  S. Ogawa,et al.  A frequent nonsense mutation in exon 1 across certain HLA-A and HLA-B alleles in leukocytes of patients with acquired aplastic anemia , 2020, Haematologica.

[4]  R Revol Núñez,et al.  [Aplastic anemia]. , 1970, Archivos Argentinos de Pediatria.

[5]  K. Akashi,et al.  Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia , 2019, Haematologica.

[6]  Yuelong Wang,et al.  CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway , 2019, Journal of cellular biochemistry.

[7]  K. Akashi,et al.  Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. , 2018, Blood advances.

[8]  S. Ogawa,et al.  Origins of myelodysplastic syndromes after aplastic anemia. , 2017, Blood.

[9]  A. Tajima,et al.  Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. , 2017, Blood.

[10]  S. Miyano,et al.  Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. , 2017, Blood.

[11]  S. Ogawa,et al.  Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia. , 2016, Experimental hematology.

[12]  J. Maciejewski,et al.  Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts , 2015, Journal of cellular and molecular medicine.

[13]  G. Mufti,et al.  Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. , 2014, Blood.

[14]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[15]  J. Maciejewski,et al.  A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate grad , 2012, Leukemia.

[16]  Haifeng Zhao,et al.  SDF-1/CXCR4 axis in myelodysplastic syndromes: correlation with angiogenesis and apoptosis. , 2012, Leukemia research.

[17]  S. Ogawa,et al.  Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. , 2011, Blood.

[18]  Xiao Li,et al.  The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome , 2012, Medical Oncology.

[19]  Bin Wang,et al.  The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling , 2011, The Journal of pathology.

[20]  C. O'keefe,et al.  SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes. , 2011, Blood.

[21]  Arne Traulsen,et al.  Somatic mutations and the hierarchy of hematopoiesis , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  A. Jankowska,et al.  Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor‐deficient PIG‐A mutant cells , 2008, British journal of haematology.

[23]  Y. Maeda,et al.  CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma , 2004, Leukemia.

[24]  K. Ishiyama,et al.  Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. , 2003, Blood.

[25]  L. Kanz,et al.  Functional response of leukaemic blasts to stromal cell‐derived factor‐1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia , 2000, British journal of haematology.

[26]  R. Paroni,et al.  Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. , 1999, Blood.

[27]  D. Alling,et al.  Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. , 1985, The Journal of clinical investigation.

[28]  C. H. Bartlett,et al.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.

[29]  E. Vellenga,et al.  Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia. , 2008, Blood.